chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Oxygen saturation decreased, Peripheral swelling, Pulmonary oedema, SARS-CoV-2 test positive, Ultrasound Doppler normal
Clinical narrative: Hospitalized 11/11/2021; COVID 19 positive 11/11/2021; Fully vaccinated plus booster  BRIEF OVERVIEW:   Discharge Provider: MD Primary Care Provider: DO Admission Date: 11/11/2021 Discharge Date: Nov 13, 2021  DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: Hypoxia [R09.02] Chronic kidney disease, unspecified CKD stage [N18.9] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1]   HOSPITAL COURSE: Pt is a 55 yr old M with PMHx of NICMP s/p Bi Vent ICD, Chronic systolic CHF, Morbid Obesity, OSA on BiPAP at night, HTN, GERD, Full vaccinated against COVID with recent booster vaccine presented to ED on 11/11 after testing positive for COVID 19. Pt was exposed to his wife - who tested positive on 11/8. Patient noted that he was short of breath and hypoxic (on pulse ox at home) with activity.  Upon ED - eval, patient required 2L O2. Chest X ray concerning for mild pulmonary vascular and interstitial prominence - pulmonary edema vs underlying infection. Pt admitted for COVID-19 pneumonia - started on Decadron and Remdesivir. Right leg noted to be enlarged - US lower extremities negative for DVT.   patient responded rapidly to remdesivir and dexamethasone. he had a slight AKI for which he was encouraged to hydrate and instructed to hold his entresto for two days, he was also set up with a follow-up lab. when i saw him he was in good spirits with no objections to leaving, he was actually comfortable on room air (was supposed to be wearing his oxygen) though did have some DOE. patient seen by pulmonary rehab prior to discharge and sent out on dexamethasone as well. all questions and concerns addressed, all meds and follow-ups reviewed.
Age: 55.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Wheezing
Clinical narrative: Hospitalized 11/11/2021; COVID 19 positive 11/11/2021; Fully vaccinated plus booster  BRIEF OVERVIEW:   Discharge Provider: MD Primary Care Provider: DO Admission Date: 11/11/2021 Discharge Date: Nov 13, 2021  DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: Hypoxia [R09.02] Chronic kidney disease, unspecified CKD stage [N18.9] Pneumonia due to COVID-19 virus [U07.1, J12.82] COVID-19 [U07.1]   HOSPITAL COURSE: Pt is a 55 yr old M with PMHx of NICMP s/p Bi Vent ICD, Chronic systolic CHF, Morbid Obesity, OSA on BiPAP at night, HTN, GERD, Full vaccinated against COVID with recent booster vaccine presented to ED on 11/11 after testing positive for COVID 19. Pt was exposed to his wife - who tested positive on 11/8. Patient noted that he was short of breath and hypoxic (on pulse ox at home) with activity.  Upon ED - eval, patient required 2L O2. Chest X ray concerning for mild pulmonary vascular and interstitial prominence - pulmonary edema vs underlying infection. Pt admitted for COVID-19 pneumonia - started on Decadron and Remdesivir. Right leg noted to be enlarged - US lower extremities negative for DVT.   patient responded rapidly to remdesivir and dexamethasone. he had a slight AKI for which he was encouraged to hydrate and instructed to hold his entresto for two days, he was also set up with a follow-up lab. when i saw him he was in good spirits with no objections to leaving, he was actually comfortable on room air (was supposed to be wearing his oxygen) though did have some DOE. patient seen by pulmonary rehab prior to discharge and sent out on dexamethasone as well. all questions and concerns addressed, all meds and follow-ups reviewed.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Painful erection
Clinical narrative: Painful erection. Pain radiates from base of penis and is especially painful just prior to ejaculation. Never once have I had this symptom before.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Bladder cancer, Chemotherapy, Lung disorder, Musculoskeletal discomfort, Platelet count decreased
Clinical narrative: On Saturday after vaccination, the Patient states he had a temp of 98.1 F as well as back and lung pressure.  Those symptoms resolved by Sunday.  On Monday, he developed a temp of 100 F.  On Tuesday, he had bloodwork done and his platelets were a 7.  The doctor's office rechecked his bloodwork on 11/9/21 and his platelets were 108.  Patient is/was a bladder cancer / chemo patient.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Instead of adding 1.8 ml of diluent to the vaccine vial to mix, 1.2 ml were added.  Patient received vaccine with no issues and stated no other symptoms a few hours  after the same day
Age: 66.0
Sex: M
Vaccine: UNK
Symptoms: Dizziness, Glassy eyes, Headache, Hypertensive crisis, Impaired driving ability
Clinical narrative: Hypertensive crisis  190/120  HR 88 O2 98  c/o HA dizziness appears lethargic with glassy eyes. States he does not go to MD and takes no meds. Did not eat today. Neuro exam normal denied CP. arm pain or jaw pain. No nausea. Dizzy and unable to drive through line. Does not see spots. Called ens for HTN crisis
Age: 66.0
Sex: M
Vaccine: UNK
Symptoms: Lethargy, Neurological examination normal
Clinical narrative: Hypertensive crisis  190/120  HR 88 O2 98  c/o HA dizziness appears lethargic with glassy eyes. States he does not go to MD and takes no meds. Did not eat today. Neuro exam normal denied CP. arm pain or jaw pain. No nausea. Dizzy and unable to drive through line. Does not see spots. Called ens for HTN crisis
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Dermatitis, Erythema, Extra dose administered, Pruritus
Clinical narrative: Booster shot. per patient, she had an existing scab at vaccination area, pharmacist that gave the shot went through the scab and now patient has red, localized and inflamed bruise that is about 3  inches big.  Pt said she noticed it the morning of the shot. Pt will go see md and has appt on 11/23. Pt said she is feeling fine and that it was itching for a bit.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site scab
Clinical narrative: Booster shot. per patient, she had an existing scab at vaccination area, pharmacist that gave the shot went through the scab and now patient has red, localized and inflamed bruise that is about 3  inches big.  Pt said she noticed it the morning of the shot. Pt will go see md and has appt on 11/23. Pt said she is feeling fine and that it was itching for a bit.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Asthenia, Culture stool, Diarrhoea, Fatigue
Clinical narrative: Patient states she began having  abdominal cramping  and diarrhea 1 hour after getting her first injection then again with the second injection. She states the cramping and diarrhea were more severe after the second injection. She also states she feels cramping, gassy, weak, and fatigued since having her second injection on the 17th.  She states she explained her symptoms to the person whom was giving the injections and was told that she should take it any way.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Flatulence, Full blood count, Metabolic function test
Clinical narrative: Patient states she began having  abdominal cramping  and diarrhea 1 hour after getting her first injection then again with the second injection. She states the cramping and diarrhea were more severe after the second injection. She also states she feels cramping, gassy, weak, and fatigued since having her second injection on the 17th.  She states she explained her symptoms to the person whom was giving the injections and was told that she should take it any way.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Heart rate irregular, Mobility decreased, Pain in extremity
Clinical narrative: On 10/29/2021, the day after the vaccine, my arm was so sore that I could not use my arm. The fatigue was really bad. I was not able to do anything. I stayed in bed and laid down on that day. Around the 4th or 5th day post vaccine I felt an irregular heartbeat and a few headaches that were not normal. I usually don't have headaches. The sore arm resolved within 24 hours. The irregular heartbeat stopped after taking antibiotics on 11/11/2021 within a week it probably came to. I continue to still have the fatigue.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash erythematous, Rash papular
Clinical narrative: Pt with c/o itching to her upper back s/p 3rd Pfizer vaccine. Pt noted to have a 2 inch raised, red rash to the upper, middle back and pt had been scratching the area since her vaccine. Pt was able to ambulate to monitoring area and did receive Zyrtec 10m po with some relief of her itching. After monitoring x30 mins pt's overall symptoms resolving and she was able to ambulate out of the Covid Vaccine Clinic with her children, and husband to drive pt home.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood creatine, Blood folate, Blood glucose normal, Blood iron, Blood thyroid stimulating hormone
Clinical narrative: Has had lightheadedness. Will start at night, sometimes carries on until the next day.. She will wake up to go to the bathroom at night, will try to go back to sleep when she experiences episode. Improves when she sits up but worsens when she lays down. Has also had dizziness. Denies room spinning sensation. Denies syncope, headache, vision changes, blurred vision, ear pain or pressure, sinus congestion, fevers, chills, chest pain, palpitations, dyspnea, or recent head trauma. BP 128/76 and pulse 67 in office. Takes her BP medication at night. Her only change is that she had 1st dose of Pfizer covid19 vaccine on 11/10/21. She received it in her left arm, initially had swelling along her left neck/clavicle and axilla. She is scheduled for her 2nd dose on 12/1/21. Has tried OTC Dramamine chewable tablets. Physical exam normal. Continuing Meclizine and has been referred to ENT for further evaluation. Will have evaluated by cardiology +/- neurology if symptoms persist or worsen.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urea, Differential white blood cell count, Dizziness, Full blood count, Iron binding capacity total increased
Clinical narrative: Has had lightheadedness. Will start at night, sometimes carries on until the next day.. She will wake up to go to the bathroom at night, will try to go back to sleep when she experiences episode. Improves when she sits up but worsens when she lays down. Has also had dizziness. Denies room spinning sensation. Denies syncope, headache, vision changes, blurred vision, ear pain or pressure, sinus congestion, fevers, chills, chest pain, palpitations, dyspnea, or recent head trauma. BP 128/76 and pulse 67 in office. Takes her BP medication at night. Her only change is that she had 1st dose of Pfizer covid19 vaccine on 11/10/21. She received it in her left arm, initially had swelling along her left neck/clavicle and axilla. She is scheduled for her 2nd dose on 12/1/21. Has tried OTC Dramamine chewable tablets. Physical exam normal. Continuing Meclizine and has been referred to ENT for further evaluation. Will have evaluated by cardiology +/- neurology if symptoms persist or worsen.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Iron binding capacity unsaturated, Metabolic function test normal, Oedema peripheral, Sleep disorder, Swelling
Clinical narrative: Has had lightheadedness. Will start at night, sometimes carries on until the next day.. She will wake up to go to the bathroom at night, will try to go back to sleep when she experiences episode. Improves when she sits up but worsens when she lays down. Has also had dizziness. Denies room spinning sensation. Denies syncope, headache, vision changes, blurred vision, ear pain or pressure, sinus congestion, fevers, chills, chest pain, palpitations, dyspnea, or recent head trauma. BP 128/76 and pulse 67 in office. Takes her BP medication at night. Her only change is that she had 1st dose of Pfizer covid19 vaccine on 11/10/21. She received it in her left arm, initially had swelling along her left neck/clavicle and axilla. She is scheduled for her 2nd dose on 12/1/21. Has tried OTC Dramamine chewable tablets. Physical exam normal. Continuing Meclizine and has been referred to ENT for further evaluation. Will have evaluated by cardiology +/- neurology if symptoms persist or worsen.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Thyroxine free normal, Transferrin saturation, Vitamin B12 normal
Clinical narrative: Has had lightheadedness. Will start at night, sometimes carries on until the next day.. She will wake up to go to the bathroom at night, will try to go back to sleep when she experiences episode. Improves when she sits up but worsens when she lays down. Has also had dizziness. Denies room spinning sensation. Denies syncope, headache, vision changes, blurred vision, ear pain or pressure, sinus congestion, fevers, chills, chest pain, palpitations, dyspnea, or recent head trauma. BP 128/76 and pulse 67 in office. Takes her BP medication at night. Her only change is that she had 1st dose of Pfizer covid19 vaccine on 11/10/21. She received it in her left arm, initially had swelling along her left neck/clavicle and axilla. She is scheduled for her 2nd dose on 12/1/21. Has tried OTC Dramamine chewable tablets. Physical exam normal. Continuing Meclizine and has been referred to ENT for further evaluation. Will have evaluated by cardiology +/- neurology if symptoms persist or worsen.
Age: 26.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: 8mins post vaccination pt c/o dizziness. Vitals: 137/91, 66, 20 Pt stable and released from vaccination site w/ mother.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza like illness, Lymph node pain, Lymphadenopathy, Pyrexia
Clinical narrative: Painful swelling in armpit lymph node two days after immunization.   Also had the expected flu-like side effects the days prior, starting about 6 hours after immunization, peaking in a fever at about hour 18, and mostly subsiding about 36 hours after immunization.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysphagia, Feeling hot, Flushing, Sensory disturbance
Clinical narrative: This RN called to assist administering RN with client who c/o difficulty swallowing, dizziness, and warmth  about 10 min after vaccination. Client  had blow by face mask oxygen when this RN entered room, uncertain when applied. Client  was A&O X4, with clear lungs and "feeling better already when 1st set of vitals taken @ 10:35am( BP 126/88, HR 84). 10:45am client was able to drink water without difficulty  after oxygen taken off at 10:40am but c/o "warmth on right side of lungs" with no DOB, BP 122/82 and HR 70. 11:10am client  stated "heat moving around chest/diaphragm, just a warmth and denied tightness." Administering RN back to assess/monitor client, 11:15am BP122/82, HR 72 , lungs clear, client c/o flushing and client released home.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Electrocardiogram abnormal, Fatigue, Pyrexia
Clinical narrative: After the first shot I was tired for 48 hours and had low grade fever.  Each time after the same symptoms have gotten worse.  All three shots gave the same, but worsening symptoms. I had abnormal EKG after my third vaccination.
Age: 105.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (temperature)-
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Anti-thyroid antibody, Blood thyroid stimulating hormone, Blood thyroid stimulating hormone decreased, Electrocardiogram, Full blood count
Clinical narrative: Heart palpitations started Saturday Oct 30 and I have had them every day since. Got lab-work done and my TSH level was low (previous TSH levels were normal, never had a thyroid problem or heart palpitations, I am a healthy individual). I am now seeing an endocrinologist .
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Palpitations, Thyroxine, Tri-iodothyronine
Clinical narrative: Heart palpitations started Saturday Oct 30 and I have had them every day since. Got lab-work done and my TSH level was low (previous TSH levels were normal, never had a thyroid problem or heart palpitations, I am a healthy individual). I am now seeing an endocrinologist .
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Blood pressure increased, Dizziness, Fatigue, Haemorrhoids thrombosed
Clinical narrative: Extreme fatigue, dizziness, severe right shoulder pain, thrombosed hemorrhoids, elevated blood pressure
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Tendonitis
Clinical narrative: Extreme fatigue, dizziness, severe right shoulder pain, thrombosed hemorrhoids, elevated blood pressure
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: 1.2 ml of diluent were added to the vaccine vial instead of 1.8 ml, making it a slight higher dose than authorized
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Polymerase chain reaction
Clinical narrative: admitted to Hospital on 10/02/2021. Unknown symptoms or reason for hospitalization.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, COVID-19, COVID-19 pneumonia, Cardiac failure congestive
Clinical narrative: Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  DATE OF ADMISSION:  11/11/2021 DATE OF DISCHARGE:  11/14/2021   DISCHARGE DIAGNOSES 1. Severe COVID pneumonia with acute hypoxic respiratory failure. 2. Community-acquired pneumonia. 3. Chronic diastolic congestive heart failure. 4. Persistent atrial fibrillation. 5. History of repair of ruptured thoracoabdominal aneurysm. 6. Gastroesophageal reflux disease.  HOSPITAL COURSE An 84-year-old gentleman presented with 5 days of cough.  See H and P for full details.  He was hypoxic and required 2 L of oxygen.  He was started on Decadron and remdesivir.  Chest x-ray showed bibasilar interstitial thickening and airspace opacities.  Procalcitonin elevated which raised the suspicion for bacterial pneumonia on top of COVID.  The patient had rather rapid resolution of his hypoxia and by the third day of admission, was on room air.  On that day, however, he had increased crackles.  He received 40 mg IV Lasix.  On the fourth hospital day, crackles were essentially resolved.  He remained on room air.  He felt that he was stable for discharge.  He received 4 days remdesivir and 4 days Decadron.  We did not feel that the fifth day of remdesivir was necessary.  He will, however, complete another 6 days of Decadron at discharge.  He received 3 days of Rocephin and doxycycline and will complete another 3 days of both at discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Chest X-ray abnormal, Chronic left ventricular failure, Condition aggravated, Cough, Gastrooesophageal reflux disease
Clinical narrative: Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  DATE OF ADMISSION:  11/11/2021 DATE OF DISCHARGE:  11/14/2021   DISCHARGE DIAGNOSES 1. Severe COVID pneumonia with acute hypoxic respiratory failure. 2. Community-acquired pneumonia. 3. Chronic diastolic congestive heart failure. 4. Persistent atrial fibrillation. 5. History of repair of ruptured thoracoabdominal aneurysm. 6. Gastroesophageal reflux disease.  HOSPITAL COURSE An 84-year-old gentleman presented with 5 days of cough.  See H and P for full details.  He was hypoxic and required 2 L of oxygen.  He was started on Decadron and remdesivir.  Chest x-ray showed bibasilar interstitial thickening and airspace opacities.  Procalcitonin elevated which raised the suspicion for bacterial pneumonia on top of COVID.  The patient had rather rapid resolution of his hypoxia and by the third day of admission, was on room air.  On that day, however, he had increased crackles.  He received 40 mg IV Lasix.  On the fourth hospital day, crackles were essentially resolved.  He remained on room air.  He felt that he was stable for discharge.  He received 4 days remdesivir and 4 days Decadron.  We did not feel that the fifth day of remdesivir was necessary.  He will, however, complete another 6 days of Decadron at discharge.  He received 3 days of Rocephin and doxycycline and will complete another 3 days of both at discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Interstitial lung disease, Lung opacity, Pneumonia, Pneumonia bacterial
Clinical narrative: Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  DATE OF ADMISSION:  11/11/2021 DATE OF DISCHARGE:  11/14/2021   DISCHARGE DIAGNOSES 1. Severe COVID pneumonia with acute hypoxic respiratory failure. 2. Community-acquired pneumonia. 3. Chronic diastolic congestive heart failure. 4. Persistent atrial fibrillation. 5. History of repair of ruptured thoracoabdominal aneurysm. 6. Gastroesophageal reflux disease.  HOSPITAL COURSE An 84-year-old gentleman presented with 5 days of cough.  See H and P for full details.  He was hypoxic and required 2 L of oxygen.  He was started on Decadron and remdesivir.  Chest x-ray showed bibasilar interstitial thickening and airspace opacities.  Procalcitonin elevated which raised the suspicion for bacterial pneumonia on top of COVID.  The patient had rather rapid resolution of his hypoxia and by the third day of admission, was on room air.  On that day, however, he had increased crackles.  He received 40 mg IV Lasix.  On the fourth hospital day, crackles were essentially resolved.  He remained on room air.  He felt that he was stable for discharge.  He received 4 days remdesivir and 4 days Decadron.  We did not feel that the fifth day of remdesivir was necessary.  He will, however, complete another 6 days of Decadron at discharge.  He received 3 days of Rocephin and doxycycline and will complete another 3 days of both at discharge.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Procalcitonin increased, Rales, SARS-CoV-2 test positive
Clinical narrative: Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  DATE OF ADMISSION:  11/11/2021 DATE OF DISCHARGE:  11/14/2021   DISCHARGE DIAGNOSES 1. Severe COVID pneumonia with acute hypoxic respiratory failure. 2. Community-acquired pneumonia. 3. Chronic diastolic congestive heart failure. 4. Persistent atrial fibrillation. 5. History of repair of ruptured thoracoabdominal aneurysm. 6. Gastroesophageal reflux disease.  HOSPITAL COURSE An 84-year-old gentleman presented with 5 days of cough.  See H and P for full details.  He was hypoxic and required 2 L of oxygen.  He was started on Decadron and remdesivir.  Chest x-ray showed bibasilar interstitial thickening and airspace opacities.  Procalcitonin elevated which raised the suspicion for bacterial pneumonia on top of COVID.  The patient had rather rapid resolution of his hypoxia and by the third day of admission, was on room air.  On that day, however, he had increased crackles.  He received 40 mg IV Lasix.  On the fourth hospital day, crackles were essentially resolved.  He remained on room air.  He felt that he was stable for discharge.  He received 4 days remdesivir and 4 days Decadron.  We did not feel that the fifth day of remdesivir was necessary.  He will, however, complete another 6 days of Decadron at discharge.  He received 3 days of Rocephin and doxycycline and will complete another 3 days of both at discharge.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Laboratory test, Rash erythematous, Rash pruritic
Clinical narrative: developed a prurtic erythematous rash on torso, head and extremities that has peristed,  she is uncertain how long after vaccination started, but thinks relatively soon and has persisted
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Cough, Decreased appetite, Encephalopathy
Clinical narrative: Hospitalized for Covid after full vaccination.  Acute hypoxemic respiratory failure due to COVID-19  Assessment & Plan Presented with 4 to 5 days of cough and fatigue. Subsequently became encephalopathic and lethargic. Was eating very little prior to admit. Found to be a bit hypoxic with volume contraction and hypokalemia as well. - Symptom onset: 10/25 - Date isolation discontinued 11/14 - Finished 10 day course of dexamethasone - Finished 5-day course of remdesivir - Now on room air  - DNR/DNI
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Hypokalaemia, Lethargy, SARS-CoV-2 test positive
Clinical narrative: Hospitalized for Covid after full vaccination.  Acute hypoxemic respiratory failure due to COVID-19  Assessment & Plan Presented with 4 to 5 days of cough and fatigue. Subsequently became encephalopathic and lethargic. Was eating very little prior to admit. Found to be a bit hypoxic with volume contraction and hypokalemia as well. - Symptom onset: 10/25 - Date isolation discontinued 11/14 - Finished 10 day course of dexamethasone - Finished 5-day course of remdesivir - Now on room air  - DNR/DNI
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Feeding disorder, Injection site pain
Clinical narrative: An hour after injection my arm became so sore I could not move it and I became extremely fatigued and dizzy. Within a few hours of those I became nauseous and by 2am I was fevering with chills. The next morning around 8am I still had chills and fainted while walking around my apartment. 11/22 I left home a few hours into my shift because I was vomiting bile, fevering and had chills. I have had a migraine since about 7pm 11/20. It is 3:18pm and I am still fevering with chills intermittently, am having an extremely hard time stating about and I have not been able to eat today.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Migraine, Pyrexia, Syncope, Vomiting
Clinical narrative: An hour after injection my arm became so sore I could not move it and I became extremely fatigued and dizzy. Within a few hours of those I became nauseous and by 2am I was fevering with chills. The next morning around 8am I still had chills and fainted while walking around my apartment. 11/22 I left home a few hours into my shift because I was vomiting bile, fevering and had chills. I have had a migraine since about 7pm 11/20. It is 3:18pm and I am still fevering with chills intermittently, am having an extremely hard time stating about and I have not been able to eat today.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Paraesthesia, Paraesthesia oral
Clinical narrative: Patient called asking for advice regarding adverse effects she was having an hour to several hours after receiving the vaccine.  She reported tingling in her lips, arms, shoulder.  She also reported a rapid heart rate that had been ongoing for at least an hour.  Pharmacist recommended visiting the ER and to take an aspirin which the patient reported that she had already taken.  Follow up call the next day was not answered and the patient has not called us back to let us know the outcome/how she is currently doing.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Blood gases abnormal, Blood pH decreased, Carbon dioxide increased, Death, Intensive care
Clinical narrative: Due to patient's complex PMH, provider asked that patient be monitored overnight after administration of COVID vaccine.  Patient was moved from PICU to general peds floor due to improvement in condition on Thursday.  Vaccine was administered that evening.  Patient did well.  Remained on room air.  Was discharged home on Saturday.  On Monday morning, father checked on patient and she was found pulseless and not breathing.  It is unclear whether or not patient was placed on home CPAP during the night.  EMS called.  Patient arrived to ED as a CPR in progress.  Patient presented with a pH of <6.  Last known well 9pm the evening prior.  Patient expired at  11/22/21 at 11:05 CST.
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Pulse absent, Respiratory arrest, Resuscitation
Clinical narrative: Due to patient's complex PMH, provider asked that patient be monitored overnight after administration of COVID vaccine.  Patient was moved from PICU to general peds floor due to improvement in condition on Thursday.  Vaccine was administered that evening.  Patient did well.  Remained on room air.  Was discharged home on Saturday.  On Monday morning, father checked on patient and she was found pulseless and not breathing.  It is unclear whether or not patient was placed on home CPAP during the night.  EMS called.  Patient arrived to ED as a CPR in progress.  Patient presented with a pH of <6.  Last known well 9pm the evening prior.  Patient expired at  11/22/21 at 11:05 CST.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered, Product preparation issue
Clinical narrative: 1.2 ml of diluent was added to the vaccine vial instead of 1.8 ml making it a slightly higher dose than authorized
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, No adverse event
Clinical narrative: Pharmacy Immunization report showed an immunization error. Patient's father filled up a self attestation form for her daughter to receive the Pfizer booster.  Reviewed and found out that the patient is years old, non immunocompromised and not eligible for a Pfizer booster at this time.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymph node pain, Myalgia, Oedema peripheral
Clinical narrative: severe chills, severe body and muscle aches, fever, severe headache for about 10 hours commencing 12 hours after vaccination.  swollen and painful lymph nodes in armpit of injection arm (ongoing for 4 days)
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: severe chills, severe body and muscle aches, fever, severe headache for about 10 hours commencing 12 hours after vaccination.  swollen and painful lymph nodes in armpit of injection arm (ongoing for 4 days)
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired medication administered to the patient.
Age: 41.0
Sex: F
Vaccine: TDAP
Symptoms: Expired product administered
Clinical narrative: AFTER ADMINISTRATION, IT WAS DISCOVERED THAT THIS BOX WAS EXPIRED BY ONE DAY (EXPIRED: 11/21/21)
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired medication administered to the patient.
Age: 32.0
Sex: F
Vaccine: FLU4
Symptoms: Erythema, Injection site pain, Pain
Clinical narrative: pt woke with pain at injection site. red raised spot  dime-size appeared on day day and grew to silver dollar.  pt experiencing localized constant pain, stinging. with no relief as of  11/22/2021.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Blood lactic acid, COVID-19, COVID-19 pneumonia, Cardiac arrest
Clinical narrative: Deceased 11/12/2021; Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: MD Admission Date: 11/11/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute UTI Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID-19   HOSPITAL COURSE: Patient is a 88 y.o. female, with a PMH of atrial fibrillation, CHF, CKD stage 3, hypertension, asthma, depression, anxiety, chronic pain, hypothyroidism, mild cognitive impairment, who presented to the emergency department with ongoing nausea/vomiting and diarrhea. In the ED the patient was noted to be hypertensive with an elevated heart rate.  EKG confirmed AFib with RVR.  She was noted to be hypoxic and placed on 3 L. Laboratory evaluation revealed an elevated white blood cell count and a lactate of 5.6 which trended down to 5.1 following 1 L of normal saline.  Chest x-ray showed extensive multifocal pulmonary opacities.  CT of the abdomen and pelvis showed evidence of COVID-19 pneumonia with small to moderate pleural effusions and marked cardiomegaly.  She did test positive for COVID-19.  Urinalysis was suspicious for urinary tract infection.  Patient was given a total of 2 L of normal saline, Decadron Rocephin. She was admitted to the hospitalist service for further care. She has an out of hospital DNR on file.    Overnight her work of breathing increased as well as oxygen demand. She also became hyopthermic and hypotensive.   Due to decline overnight and wishes to be DNR patient's family was contacted and planned to be at bedside by morning however a RAP was called at 715am for hypotension. On evaluation the patient had no chest rise and was not breathing. Tele showed asystole. Pronunciation of death was completed at 0720 and family was informed (daughter and son-2 children. Her other son was not able to be reached) along with patients PCP. Death certification to be completed by admitting physician.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Cardiac telemetry abnormal, Cardiomegaly, Chest X-ray abnormal, Computerised tomogram abdomen abnormal, Death
Clinical narrative: Deceased 11/12/2021; Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: MD Admission Date: 11/11/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute UTI Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID-19   HOSPITAL COURSE: Patient is a 88 y.o. female, with a PMH of atrial fibrillation, CHF, CKD stage 3, hypertension, asthma, depression, anxiety, chronic pain, hypothyroidism, mild cognitive impairment, who presented to the emergency department with ongoing nausea/vomiting and diarrhea. In the ED the patient was noted to be hypertensive with an elevated heart rate.  EKG confirmed AFib with RVR.  She was noted to be hypoxic and placed on 3 L. Laboratory evaluation revealed an elevated white blood cell count and a lactate of 5.6 which trended down to 5.1 following 1 L of normal saline.  Chest x-ray showed extensive multifocal pulmonary opacities.  CT of the abdomen and pelvis showed evidence of COVID-19 pneumonia with small to moderate pleural effusions and marked cardiomegaly.  She did test positive for COVID-19.  Urinalysis was suspicious for urinary tract infection.  Patient was given a total of 2 L of normal saline, Decadron Rocephin. She was admitted to the hospitalist service for further care. She has an out of hospital DNR on file.    Overnight her work of breathing increased as well as oxygen demand. She also became hyopthermic and hypotensive.   Due to decline overnight and wishes to be DNR patient's family was contacted and planned to be at bedside by morning however a RAP was called at 715am for hypotension. On evaluation the patient had no chest rise and was not breathing. Tele showed asystole. Pronunciation of death was completed at 0720 and family was informed (daughter and son-2 children. Her other son was not able to be reached) along with patients PCP. Death certification to be completed by admitting physician.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea, Electrocardiogram abnormal, General physical health deterioration, Heart rate increased
Clinical narrative: Deceased 11/12/2021; Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: MD Admission Date: 11/11/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute UTI Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID-19   HOSPITAL COURSE: Patient is a 88 y.o. female, with a PMH of atrial fibrillation, CHF, CKD stage 3, hypertension, asthma, depression, anxiety, chronic pain, hypothyroidism, mild cognitive impairment, who presented to the emergency department with ongoing nausea/vomiting and diarrhea. In the ED the patient was noted to be hypertensive with an elevated heart rate.  EKG confirmed AFib with RVR.  She was noted to be hypoxic and placed on 3 L. Laboratory evaluation revealed an elevated white blood cell count and a lactate of 5.6 which trended down to 5.1 following 1 L of normal saline.  Chest x-ray showed extensive multifocal pulmonary opacities.  CT of the abdomen and pelvis showed evidence of COVID-19 pneumonia with small to moderate pleural effusions and marked cardiomegaly.  She did test positive for COVID-19.  Urinalysis was suspicious for urinary tract infection.  Patient was given a total of 2 L of normal saline, Decadron Rocephin. She was admitted to the hospitalist service for further care. She has an out of hospital DNR on file.    Overnight her work of breathing increased as well as oxygen demand. She also became hyopthermic and hypotensive.   Due to decline overnight and wishes to be DNR patient's family was contacted and planned to be at bedside by morning however a RAP was called at 715am for hypotension. On evaluation the patient had no chest rise and was not breathing. Tele showed asystole. Pronunciation of death was completed at 0720 and family was informed (daughter and son-2 children. Her other son was not able to be reached) along with patients PCP. Death certification to be completed by admitting physician.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypotension, Hypothermia, Hypoxia, Laboratory test
Clinical narrative: Deceased 11/12/2021; Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: MD Admission Date: 11/11/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute UTI Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID-19   HOSPITAL COURSE: Patient is a 88 y.o. female, with a PMH of atrial fibrillation, CHF, CKD stage 3, hypertension, asthma, depression, anxiety, chronic pain, hypothyroidism, mild cognitive impairment, who presented to the emergency department with ongoing nausea/vomiting and diarrhea. In the ED the patient was noted to be hypertensive with an elevated heart rate.  EKG confirmed AFib with RVR.  She was noted to be hypoxic and placed on 3 L. Laboratory evaluation revealed an elevated white blood cell count and a lactate of 5.6 which trended down to 5.1 following 1 L of normal saline.  Chest x-ray showed extensive multifocal pulmonary opacities.  CT of the abdomen and pelvis showed evidence of COVID-19 pneumonia with small to moderate pleural effusions and marked cardiomegaly.  She did test positive for COVID-19.  Urinalysis was suspicious for urinary tract infection.  Patient was given a total of 2 L of normal saline, Decadron Rocephin. She was admitted to the hospitalist service for further care. She has an out of hospital DNR on file.    Overnight her work of breathing increased as well as oxygen demand. She also became hyopthermic and hypotensive.   Due to decline overnight and wishes to be DNR patient's family was contacted and planned to be at bedside by morning however a RAP was called at 715am for hypotension. On evaluation the patient had no chest rise and was not breathing. Tele showed asystole. Pronunciation of death was completed at 0720 and family was informed (daughter and son-2 children. Her other son was not able to be reached) along with patients PCP. Death certification to be completed by admitting physician.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Lung opacity, Nausea, Pleural effusion, SARS-CoV-2 test positive, Sepsis
Clinical narrative: Deceased 11/12/2021; Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: MD Admission Date: 11/11/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute UTI Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID-19   HOSPITAL COURSE: Patient is a 88 y.o. female, with a PMH of atrial fibrillation, CHF, CKD stage 3, hypertension, asthma, depression, anxiety, chronic pain, hypothyroidism, mild cognitive impairment, who presented to the emergency department with ongoing nausea/vomiting and diarrhea. In the ED the patient was noted to be hypertensive with an elevated heart rate.  EKG confirmed AFib with RVR.  She was noted to be hypoxic and placed on 3 L. Laboratory evaluation revealed an elevated white blood cell count and a lactate of 5.6 which trended down to 5.1 following 1 L of normal saline.  Chest x-ray showed extensive multifocal pulmonary opacities.  CT of the abdomen and pelvis showed evidence of COVID-19 pneumonia with small to moderate pleural effusions and marked cardiomegaly.  She did test positive for COVID-19.  Urinalysis was suspicious for urinary tract infection.  Patient was given a total of 2 L of normal saline, Decadron Rocephin. She was admitted to the hospitalist service for further care. She has an out of hospital DNR on file.    Overnight her work of breathing increased as well as oxygen demand. She also became hyopthermic and hypotensive.   Due to decline overnight and wishes to be DNR patient's family was contacted and planned to be at bedside by morning however a RAP was called at 715am for hypotension. On evaluation the patient had no chest rise and was not breathing. Tele showed asystole. Pronunciation of death was completed at 0720 and family was informed (daughter and son-2 children. Her other son was not able to be reached) along with patients PCP. Death certification to be completed by admitting physician.
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection, Urine analysis abnormal, Vomiting, White blood cell count increased
Clinical narrative: Deceased 11/12/2021; Hospitalized 11/11/2021; COVID-19 positive 11/10/2021; fully vaccinated  BRIEF OVERVIEW: Discharge Provider: DO Primary Care Physician at Discharge: MD Admission Date: 11/11/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute UTI Sepsis, due to unspecified organism, unspecified whether acute organ dysfunction present COVID-19   HOSPITAL COURSE: Patient is a 88 y.o. female, with a PMH of atrial fibrillation, CHF, CKD stage 3, hypertension, asthma, depression, anxiety, chronic pain, hypothyroidism, mild cognitive impairment, who presented to the emergency department with ongoing nausea/vomiting and diarrhea. In the ED the patient was noted to be hypertensive with an elevated heart rate.  EKG confirmed AFib with RVR.  She was noted to be hypoxic and placed on 3 L. Laboratory evaluation revealed an elevated white blood cell count and a lactate of 5.6 which trended down to 5.1 following 1 L of normal saline.  Chest x-ray showed extensive multifocal pulmonary opacities.  CT of the abdomen and pelvis showed evidence of COVID-19 pneumonia with small to moderate pleural effusions and marked cardiomegaly.  She did test positive for COVID-19.  Urinalysis was suspicious for urinary tract infection.  Patient was given a total of 2 L of normal saline, Decadron Rocephin. She was admitted to the hospitalist service for further care. She has an out of hospital DNR on file.    Overnight her work of breathing increased as well as oxygen demand. She also became hyopthermic and hypotensive.   Due to decline overnight and wishes to be DNR patient's family was contacted and planned to be at bedside by morning however a RAP was called at 715am for hypotension. On evaluation the patient had no chest rise and was not breathing. Tele showed asystole. Pronunciation of death was completed at 0720 and family was informed (daughter and son-2 children. Her other son was not able to be reached) along with patients PCP. Death certification to be completed by admitting physician.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired medication administered to the patient.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: NO ADVERSE EVENTS AS OF YET, NOR ANY TREATMENT
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Extremely swollen lymph node under the armpit on the side of the injection.
Age: 5.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMRV
Symptoms: Extra dose administered, Inappropriate schedule of product administration, Wrong product administered
Clinical narrative: Patient was given vaccine that he did not need. He had had Hep A #1 on 08/03/2021 and should come back in Feb 2022 for his second dose. I failed to recognize this and have him his second hep A 11/22/21. Patient was given Proquad 11/22/21. He had his 2nd MMR 08/03/2021 and did not need this. He did need his second varicella today-11/22/21. Quadracel was given. He had Quadracel 08/23/2021 for his 5th dtap and 4th polio. He did not need quadracel today.  I explained to mom afterward that I made  a mistake and that he should come back in Feb 2022 for his second Hep A. Mom was given a credit for his vaccines as she paid today. I had already told her side effects and symptoms with the assistance of the interpreter as well as what to watch for with an allergic reaction. I informed mom that these extra vaccines should not cause harm but to watch for side effects.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Error: Improper Storage (temperature).
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Nodule, Pain
Clinical narrative: Patient complained of a knot that seemed to move near her collar bone that appeared on the left side on the shot side on nov 20. Other symptoms include pain from knot (size of marble) when walking around. no other symptoms
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Vaccine administered beyond the Best Used Date but before expiration date.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, Syncope, Unresponsive to stimuli
Clinical narrative: PT FAINT IMMEDIATELY FOLLOWING ADMINISTRATION OF JANSSEN VACCINE. PT REPORTS FAINTING AFTER BLOOD DRAWS BUT NEVER WITH VACCINATIONS.  CALLED 911, PT DID NOT WANT TO GO TO HOSPITAL FOR OBSERVATION. ONCE RESPONSIVE, HAD SIPS OF ORANGE JUICE AND WATER. STATED SHE WAS FEELING BETTER.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too High-
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injected limb mobility decreased, Injection site pain, Injection site paraesthesia, Injection site reaction
Clinical narrative: PATIENT CAME NEXT DAY ON THURDAY AT 3:47 PM COMPLAINING OF PAIN AT THE SITE OF INJECTIONS STARTED THE NIGHT OF THE VACCINATION, THE PAIN WAS DESCRIBED AS TINGLING, NERVE PAIN AND PAIN AT THE SHOULDER, SHE TOOK SOME TYLENOL, WHICH MADE IT BETTER, HOW EVER, THE PAIN GOT WORSE THE NEXT DAY THAT SHE COULD NOT MOVE THE ARM AROUND, SHE HAD TO GO TO URGENET CARE AND SHE WAS TOLD AT THE URGENT CARE OFFICE THAT THE SITE OF INJECTIONS WAS VERY HIGH. IF THE PAIN CONTINUES MORE THAN A WEEK, PATIENT SHOULD SEEK MEDICAL HELP. THE PATIENT KEPT TAKING TYLENOL WHICH HLEPS LESSEN THE PAIN. UPON COMING TO THE PHARMACY, I OBSERVED THE SITE OF INJUECTION AND IT WAS VERY HIGH CLOSE TO SHOULDER AND FAR AWAY FROM DELTIOD MUSCLE
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Product administered at inappropriate site
Clinical narrative: PATIENT CAME NEXT DAY ON THURDAY AT 3:47 PM COMPLAINING OF PAIN AT THE SITE OF INJECTIONS STARTED THE NIGHT OF THE VACCINATION, THE PAIN WAS DESCRIBED AS TINGLING, NERVE PAIN AND PAIN AT THE SHOULDER, SHE TOOK SOME TYLENOL, WHICH MADE IT BETTER, HOW EVER, THE PAIN GOT WORSE THE NEXT DAY THAT SHE COULD NOT MOVE THE ARM AROUND, SHE HAD TO GO TO URGENET CARE AND SHE WAS TOLD AT THE URGENT CARE OFFICE THAT THE SITE OF INJECTIONS WAS VERY HIGH. IF THE PAIN CONTINUES MORE THAN A WEEK, PATIENT SHOULD SEEK MEDICAL HELP. THE PATIENT KEPT TAKING TYLENOL WHICH HLEPS LESSEN THE PAIN. UPON COMING TO THE PHARMACY, I OBSERVED THE SITE OF INJUECTION AND IT WAS VERY HIGH CLOSE TO SHOULDER AND FAR AWAY FROM DELTIOD MUSCLE
Age: 55.0
Sex: F
Vaccine: COVID19, FLU4
Symptoms: Fatigue, Swelling of eyelid
Clinical narrative: Received both Flu and  Covid booster on 11/20/2021 at 4:00 pm. 11/21/2021, only side effect was a little fatigue. 11/22/2021 woke up at 5:30 am and both eyed were swollen shut. I looked like a toad.